61 related articles for article (PubMed ID: 18382268)
1. Central role of rho kinase in lipopolysaccharide-induced platelet capture on venous endothelium.
Slotta JE; Braun OO; Menger MD; Thorlacius H
J Investig Med; 2008 Apr; 56(4):720-5. PubMed ID: 18382268
[TBL] [Abstract][Full Text] [Related]
2. Capture of platelets to the endothelium of the femoral vein is mediated by CD62P and CD162.
Slotta JE; Braun OO; Menger MD; Thorlacius H
Platelets; 2009 Nov; 20(7):505-12. PubMed ID: 19852690
[TBL] [Abstract][Full Text] [Related]
3. Fasudil, a Rho-kinase inhibitor, inhibits leukocyte adhesion in inflamed large blood vessels in vivo.
Slotta JE; Braun OO; Menger MD; Thorlacius H
Inflamm Res; 2006 Sep; 55(9):364-7. PubMed ID: 17122957
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of fasudil, a Rho-kinase inhibitor, on chemokine expression, leukocyte recruitment, and hepatocellular apoptosis in septic liver injury.
Thorlacius K; Slotta JE; Laschke MW; Wang Y; Menger MD; Jeppsson B; Thorlacius H
J Leukoc Biol; 2006 May; 79(5):923-31. PubMed ID: 16641138
[TBL] [Abstract][Full Text] [Related]
5. Fasudil attenuates lipopolysaccharide-induced acute lung injury in mice through the Rho/Rho kinase pathway.
Li Y; Wu Y; Wang Z; Zhang XH; Wu WK
Med Sci Monit; 2010 Apr; 16(4):BR112-118. PubMed ID: 20357711
[TBL] [Abstract][Full Text] [Related]
6. Fasudil inhibits neutrophil-endothelial cell interactions by regulating the expressions of GRP78 and BMPR2.
Wang J; Xu J; Zhao X; Xie W; Wang H; Kong H
Exp Cell Res; 2018 Apr; 365(1):97-105. PubMed ID: 29481792
[TBL] [Abstract][Full Text] [Related]
7. Fasudil, a Rho-kinase inhibitor, attenuates lipopolysaccharide-induced vascular hyperpermeability and colonic muscle relaxation in guinea pigs.
Suzuki K; Nemoto K; Ninomiya N; Kuno M; Kubota M; Yokota H
J Surg Res; 2012 Nov; 178(1):352-7. PubMed ID: 22487385
[TBL] [Abstract][Full Text] [Related]
8. Primary and secondary capture of platelets onto inflamed femoral artery endothelium is dependent on P-selectin and PSGL-1.
Braun OO; Slotta JE; Menger MD; Erlinge D; Thorlacius H
Eur J Pharmacol; 2008 Sep; 592(1-3):128-32. PubMed ID: 18644365
[TBL] [Abstract][Full Text] [Related]
9. Rho-kinase signalling mediates endotoxin hypersensitivity after partial hepatectomy.
Slotta JE; Laschke MW; Menger MD; Thorlacius H
Br J Surg; 2008 Aug; 95(8):976-84. PubMed ID: 18563790
[TBL] [Abstract][Full Text] [Related]
10. Intravital Microscopy of Leukocyte-endothelial and Platelet-leukocyte Interactions in Mesenterial Veins in Mice.
Herr N; Mauler M; Bode C; Duerschmied D
J Vis Exp; 2015 Aug; (102):e53077. PubMed ID: 26325284
[TBL] [Abstract][Full Text] [Related]
11. Long term Rho-kinase inhibition ameliorates endothelial dysfunction in LDL-Receptor deficient mice.
Steioff K; Rütten H; Busch AE; Plettenburg O; Ivashchenko Y; Löhn M
Eur J Pharmacol; 2005 Apr; 512(2-3):247-9. PubMed ID: 15840411
[TBL] [Abstract][Full Text] [Related]
12. The Rho-kinase inhibitor Y-27632 inhibits cholestasis-induced platelet interactions in the hepatic microcirculation.
Laschke MW; Dold S; Menger MD; Jeppsson B; Thorlacius H
Microvasc Res; 2009 Jun; 78(1):95-9. PubMed ID: 19374910
[TBL] [Abstract][Full Text] [Related]
13. Interactions between blood cells and retinal endothelium in endotoxic sepsis.
Tsujikawa A; Kiryu J; Yamashiro K; Nonaka A; Nishijima K; Honda Y; Ogura Y
Hypertension; 2000 Aug; 36(2):250-8. PubMed ID: 10948086
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection.
Rikitake Y; Kim HH; Huang Z; Seto M; Yano K; Asano T; Moskowitz MA; Liao JK
Stroke; 2005 Oct; 36(10):2251-7. PubMed ID: 16141422
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Rho-kinase attenuates endothelial-leukocyte interaction during ischemia-reperfusion injury.
Wang QM; Stalker TJ; Gong Y; Rikitake Y; Scalia R; Liao JK
Vasc Med; 2012 Dec; 17(6):379-85. PubMed ID: 23015643
[TBL] [Abstract][Full Text] [Related]
16. Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis.
Wang YX; Martin-McNulty B; da Cunha V; Vincelette J; Lu X; Feng Q; Halks-Miller M; Mahmoudi M; Schroeder M; Subramanyam B; Tseng JL; Deng GD; Schirm S; Johns A; Kauser K; Dole WP; Light DR
Circulation; 2005 May; 111(17):2219-26. PubMed ID: 15851596
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo assays to analyze the contribution of Rho kinase in angiogenesis.
Sawada K; Morishige K; Mabuchi S; Ogata S; Kawase C; Sakata M; Kimura T
Methods Enzymol; 2008; 439():395-412. PubMed ID: 18374179
[TBL] [Abstract][Full Text] [Related]
18. Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease.
Nohria A; Grunert ME; Rikitake Y; Noma K; Prsic A; Ganz P; Liao JK; Creager MA
Circ Res; 2006 Dec; 99(12):1426-32. PubMed ID: 17095725
[TBL] [Abstract][Full Text] [Related]
19. Long-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in mice.
Abe K; Tawara S; Oi K; Hizume T; Uwatoku T; Fukumoto Y; Kaibuchi K; Shimokawa H
J Cardiovasc Pharmacol; 2006 Dec; 48(6):280-5. PubMed ID: 17204906
[TBL] [Abstract][Full Text] [Related]
20. Rho-kinase inhibition acutely augments blood flow in focal cerebral ischemia via endothelial mechanisms.
Shin HK; Salomone S; Potts EM; Lee SW; Millican E; Noma K; Huang PL; Boas DA; Liao JK; Moskowitz MA; Ayata C
J Cereb Blood Flow Metab; 2007 May; 27(5):998-1009. PubMed ID: 17033691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
